scholarly article | Q13442814 |
P2093 | author name string | Juan Zhang | |
Qin Gao | |||
XiaoPing Gu | |||
ZhengLiang Ma | |||
JunHua Wang | |||
FengMei Mei | |||
XiaoFang Zhou | |||
XiaoPing Xia | |||
YanQing Jin | |||
P2860 | cites work | Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist | Q24672789 |
Heteromeric NMDA receptors: molecular and functional distinction of subtypes | Q28182183 | ||
Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain | Q28505978 | ||
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
Neuronal plasticity: increasing the gain in pain | Q29615421 | ||
Quantitative assessment of tactile allodynia in the rat paw | Q29617366 | ||
Ethical guidelines for investigations of experimental pain in conscious animals | Q29617510 | ||
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons | Q33907117 | ||
Malignant bone pain: pathophysiology and treatment | Q34418896 | ||
NMDA receptors as targets for drug action in neuropathic pain. | Q34430622 | ||
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia | Q34621303 | ||
Recent progress in the pharmacotherapy of cancer pain | Q34734247 | ||
The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. | Q35031245 | ||
Spinal and supraspinal contributions to central sensitization in peripheral neuropathy | Q36281892 | ||
The use of ketamine as adjuvant therapy to control severe pain | Q37079474 | ||
Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain | Q37239670 | ||
Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology | Q39415446 | ||
Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain | Q40610103 | ||
NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride | Q42554953 | ||
Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats | Q44264983 | ||
Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat. | Q45095142 | ||
Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia. | Q45106035 | ||
Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique | Q45194967 | ||
mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity | Q45274101 | ||
Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization | Q46442854 | ||
NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists | Q46693237 | ||
Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. | Q46937094 | ||
NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice | Q48321527 | ||
Ketamine as an adjuvant for treatment of cancer pain in children and adolescents | Q48606176 | ||
Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain | Q48664516 | ||
Breakthrough pain: characteristics and impact in patients with cancer pain. | Q51089873 | ||
Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic | Q51714386 | ||
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. | Q52535137 | ||
P433 | issue | 5 | |
P304 | page(s) | 496-502 | |
P577 | publication date | 2009-10-07 | |
P1433 | published in | European Journal of Pain | Q4548992 |
P1476 | title | The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain | |
P478 | volume | 14 |
Q35069143 | 2020 Foresight: Envisioning Therapeutic Innovations for Pain |
Q38789599 | A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2. |
Q28534748 | A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats |
Q36125514 | Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats |
Q36841355 | Activation of spinal MrgC-Gi-NR2B-nNOS signaling pathway by Mas oncogene-related gene C receptor agonist bovine adrenal medulla 8-22 attenuates bone cancer pain in mice |
Q35479514 | Activation of spinal alpha-7 nicotinic acetylcholine receptor attenuates remifentanil-induced postoperative hyperalgesia |
Q51059261 | Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain. |
Q36139992 | Analgesic effects of NB001 on mouse models of arthralgia |
Q47980674 | Anxiolytic-like effects of α-asarone in a mouse model of chronic pain |
Q34489274 | Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord |
Q48648830 | Brain-derived neurotrophic factor modulates N-methyl-D-aspartate receptor activation in a rat model of cancer-induced bone pain |
Q37114764 | CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice |
Q38175134 | Calcium-permeable ion channels in pain signaling |
Q89545828 | Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell |
Q30831131 | Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain |
Q42409094 | Effects of Src-kinase inhibition in cancer-induced bone pain. |
Q38494461 | Efficacy of Continuous S(+)-Ketamine Infusion for Postoperative Pain Control: A Randomized Placebo-Controlled Trial |
Q38029596 | Glutamate signaling in healthy and diseased bone |
Q34221568 | Intraperitoneal Injection of Thalidomide Attenuates Bone Cancer Pain and Decreases Spinal Tumor Necrosis Factor-α Expression in a Mouse Model |
Q53533652 | Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord. |
Q34328380 | Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat model |
Q36010727 | Mas-Related Gene (Mrg) C Activation Attenuates Bone Cancer Pain via Modulating Gi and NR2B |
Q37709186 | Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice |
Q36409596 | Overview of Glutamatergic Dysregulation in Central Pathologies |
Q33637280 | PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain |
Q46441995 | Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice |
Q36520170 | Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA |
Q34429471 | Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats |
Q35041376 | Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain |
Q33881060 | The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain |
Q90084665 | The Ubiquitination of Spinal MrgC Alleviates Bone Cancer Pain and Reduces Intracellular Calcium Concentration in Spinal Neurons in Mice |
Q34167635 | The neurobiology of cancer pain |
Q41993519 | Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine |